Constitutively	O
active	O
RAS	O
signaling	O
reduces	O
1	O
,	O
25	O
dihydroxyvitamin	O
D	O
-	O
mediated	O
gene	O
transcription	O
in	O
intestinal	O
epithelial	O
cells	O
by	O
reducing	O
vitamin	O
D	O
receptor	O
expression	O
.	O


High	O
vitamin	O
D	O
status	O
is	O
associated	O
with	O
reduced	O
colon	O
cancer	O
risk	O
but	O
these	O
studies	O
ignore	O
the	O
diversity	O
in	O
the	O
molecular	O
etiology	O
of	O
colon	O
cancer	O
.	O


RAS	O
activating	O
mutations	O
are	O
common	O
in	O
colon	O
cancer	O
and	O
they	O
activate	O
pro	O
-	O
proliferative	O
signaling	O
pathways	O
.	O


We	O
examined	O
the	O
impact	O
of	O
RAS	O
activating	O
mutations	O
on	O
1	O
,	O
25	O
dihydroxyvitamin	O
D	O
(	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
)	O
-	O
mediated	O
gene	O
expression	O
in	O
cultured	O
colon	O
and	O
intestinal	O
cell	O
lines	O
.	O


Transient	O
transfection	O
of	O
Caco	O
-	O
2	O
cells	O
with	O
a	O
constitutively	O
active	O
mutant	O
K	O
-	O
RAS	O
(	O
G12	O
V	O
)	O
significantly	O
reduced	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
-	O
induced	O
activity	O
of	O
both	O
a	O
human	O
25	O
-	O
hydroxyvitamin	O
D	O
,	O
24	O
hydroxyase	O
(	O
CYP24A1	O
)	O
promoter	O
-	O
luciferase	O
and	O
an	O
artificial	O
3X	O
vitamin	O
D	O
response	O
element	O
(	O
VDRE	O
)	O
promoter	O
-	O
luciferase	O
reporter	O
gene	O
.	O


Young	O
Adult	O
Mouse	O
Colon	O
(	O
YAMC	O
)	O
and	O
Rat	O
Intestinal	O
Epithelial	O
(	O
RIE	O
)	O
cell	O
lines	O
with	O
stable	O
expression	O
of	O
mutant	O
H	O
-	O
RAS	O
had	O
suppressed	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
-	O
mediated	O
induction	O
of	O
CYP24A1	O
mRNA	O
.	O


The	O
RAS	O
effects	O
were	O
associated	O
with	O
lower	O
Vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
mRNA	O
and	O
protein	O
levels	O
in	O
YAMC	O
and	O
RIE	O
cells	O
and	O
they	O
could	O
be	O
partially	O
reversed	O
by	O
VDR	O
overexpression	O
.	O


RAS	O
-	O
mediated	O
suppression	O
of	O
VDR	O
levels	O
was	O
not	O
due	O
to	O
either	O
reduced	O
VDR	O
mRNA	O
stability	O
or	O
increased	O
VDR	O
gene	O
methylation	O
.	O


However	O
,	O
chromatin	O
accessibility	O
to	O
the	O
VDR	O
gene	O
at	O
the	O
proximal	O
promoter	O
(	O
-	O
300bp	O
)	O
,	O
an	O
enhancer	O
region	O
at	O
-	O
6kb	O
,	O
and	O
an	O
enhancer	O
region	O
located	O
in	O
exon	O
3	O
was	O
significantly	O
reduced	O
in	O
RAS	O
transformed	O
YAMC	O
cells	O
(	O
YAMC	O
-	O
RAS	O
)	O
.	O


These	O
data	O
show	O
that	O
constitutively	O
active	O
RAS	O
signaling	O
suppresses	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
-	O
mediated	O
gene	O
transcription	O
in	O
colon	O
epithelial	O
cells	O
by	O
reducing	O
VDR	O
gene	O
transcription	O
but	O
the	O
mechanism	O
for	O
this	O
suppression	O
is	O
not	O
yet	O
known	O
.	O


These	O
data	O
suggest	O
that	O
cancers	O
with	O
RAS	O
-	O
activating	O
mutations	O
may	O
be	O
less	O
responsive	O
to	O
vitamin	O
D	O
mediated	O
treatment	O
or	O
chemoprevention	O
.	O
